Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

This study has been completed.

Study NCT00035022 Information provided by BioCryst Pharmaceuticals

First Received: May 2, 2002 Last Updated: January 12, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2004
Estimated Primary Completion Date:	No date given